enhanc
polymeras
chain
reaction
pcr
assay
detect
coronaviru
associ
sever
acut
respiratori
syndrom
sarscov
develop
target
gene
preamplif
step
preced
taqman
realtim
fluoresc
pcr
clinic
sampl
collect
patient
diagnos
suspect
probabl
sar
case
analyz
convent
pcr
follow
agaros
gel
electrophoresi
convent
taqman
realtim
pcr
enhanc
taqman
realtim
pcr
assay
amplicon
size
expect
sarscov
obtain
sampl
use
enhanc
realtim
pcr
method
convent
pcr
realtim
pcr
alon
identifi
fewer
sarscov
posit
case
result
confirm
viral
cultur
case
limit
detect
enhanc
realtim
pcr
method
fold
higher
standard
realtim
pcr
assay
fold
higher
convent
pcr
method
increas
sensit
assay
may
help
control
spread
diseas
futur
sar
outbreak
realtim
pcr
sarscoronaviru
incorpor
target
gene
preamplif
juli
case
sar
report
world
health
organ
fatal
worldwid
revis
estim
septemb
hong
kong
alon
case
death
novel
coronaviru
name
urbani
sarsassoci
coronaviru
sarscov
appear
respons
diseas
diseas
continu
pose
seriou
threat
frontlin
health
worker
member
medic
commun
intern
travel
among
other
addit
econom
cost
global
outbreak
sever
sever
assay
base
polymeras
chain
reaction
pcr
specif
sarscov
devis
use
genet
inform
provid
sever
group
rapid
diagnosi
identifi
cornerston
contain
regard
sar
infecti
diseas
sarscov
found
sputum
throat
swab
serum
lung
kidney
bone
marrow
faec
among
other
howev
neg
result
pcr
necessarili
mean
patient
sar
mani
factor
affect
viral
nucleic
acid
detect
includ
insensit
primer
probe
use
amplif
protocol
absenc
sarscov
infect
observ
ill
caus
anoth
infecti
agent
fals
neg
pcr
result
specimen
collect
time
viru
genet
materi
present
undetect
level
current
method
therefor
import
devis
method
suffici
sensit
screen
effect
sarscov
nest
pcr
method
product
initi
round
amplif
use
templat
subsequ
amplif
well
known
increas
fidel
sensit
detect
mani
target
gene
preamplif
method
consid
unnecessari
variou
realtim
pcr
applic
account
gener
superior
sensit
convent
pcr
techniqu
howev
situat
target
gene
interest
rare
andor
present
background
contamin
preamplif
might
use
adjunct
improv
limit
detect
incorpor
convent
pcr
preamplif
step
protocol
detect
sarscov
studi
compar
sensit
specif
enhanc
realtim
fluoresc
pcr
assay
sarscov
amplif
techniqu
increas
sensit
detect
sarscov
would
major
benefit
screen
suspect
sar
patient
rapidli
effici
confin
spread
diseas
patient
sampl
sampl
collect
patient
categor
suspect
probabl
sar
case
accord
guidelin
adopt
time
outbreak
princ
wale
hospit
shatin
hong
kong
sar
china
april
sampl
collect
patient
categor
suspect
probabl
sar
case
new
territori
east
cluster
hospit
hong
kong
april
sampl
primarili
nasopharyng
aspir
also
includ
nasal
swab
rectal
swab
throat
swab
throat
aspir
periton
swab
prepar
cdna
total
rna
sampl
isol
use
qiaamp
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
rna
convert
cdna
use
superscript
ii
rnase
h
revers
transcriptas
invitrogen
accord
manufactur
instruct
except
ng
random
hexam
primer
use
place
oligo
nucleasefre
water
use
place
rnaseout
recombin
ribonucleas
inhibitor
primer
probe
varieti
primer
probe
convent
realtim
pcr
use
tabl
comparison
purpos
primer
set
describ
bernardnocht
institut
tropic
medicin
hamburg
germani
govern
viru
unit
hong
kong
sar
china
use
new
set
primer
probe
convent
taqman
realtim
pcr
deriv
base
rnadepend
rna
polymeras
gene
sarscov
isol
genbank
access
convent
pcr
total
volum
follow
compon
mix
nucleasefre
water
mm
dntp
u
platinum
taq
dna
polymeras
invitrogen
mm
mgcl
pcr
buffer
primer
lm
cdna
templat
ng
pcr
amplif
perform
mastercycl
eppendorf
follow
temperatur
profil
denatur
min
cycl
reduct
cycl
carri
follow
cycl
amplif
product
analyz
electrophoresi
constant
current
wv
agaros
gel
follow
stain
ethidium
bromid
taqman
realtim
fluoresc
pcr
total
volum
follow
compon
mix
nucleasefre
water
qpcr
mastermix
eurogentec
egt
group
sera
belgium
compris
mm
datp
dctp
dgtp
mm
dutp
hotstart
taq
dna
polymeras
mgcl
uracilnglycosylas
passiv
refer
primer
c
lm
primer
lm
probe
e
lm
cdna
templat
ng
realtim
amplif
perform
abi
prism
sequenc
detector
appli
biosystem
follow
temperatur
profil
initi
incub
min
min
cycl
min
perform
enhanc
realtim
pcr
novel
realtim
pcr
assay
develop
salient
featur
new
assay
use
amplif
product
initi
round
convent
pcr
templat
second
round
taqman
realtim
fluoresc
pcr
use
amplif
profil
describ
increas
sensit
sarscov
detect
primer
use
initi
preamplif
convent
pcr
realtim
pcr
stage
sequenc
product
amplif
reaction
sequenc
ensur
amplicon
correspond
intend
target
sequenc
sequenc
reaction
perform
use
commerci
avail
sequenc
kit
appli
biosystem
accord
manufactur
instruct
dna
sequenc
obtain
resolv
sequenc
reaction
sequenc
system
appli
biosystem
dna
sequenc
analyz
use
blast
sequenc
comparison
tool
avail
nation
center
biotechnolog
inform
ncbi
http
wwwncbinlmnihgov
viral
cultur
isol
specimen
inocul
vero
cell
monolay
examin
daili
day
presenc
cytopath
effect
cpe
cell
cultur
show
cpe
passag
anoth
vero
cell
monolay
show
cpe
within
day
incub
addit
revers
transcript
pcr
rtpcr
use
primer
tabl
use
examin
supernat
posit
cell
cultur
nucleic
acid
amplif
rapidli
becom
standard
laboratori
method
confirm
diagnosi
mani
diseas
demonstr
directli
presenc
infecti
organ
patient
tissu
method
becom
indispens
sar
outbreak
specif
sensit
enabl
confirm
infect
rapidli
allow
effect
antivir
therapi
monitor
sever
pcrbase
diagnost
assay
sar
coronaviru
describ
sar
diagnost
assay
reli
upon
demonstr
presenc
host
antibodi
sarscov
also
develop
eg
elisa
immunofluoresc
howev
test
often
lack
sensit
nucleic
acid
method
detect
newli
infect
patient
day
requir
antibodi
reach
detect
level
convent
pcr
method
use
varieti
primer
specif
region
sarscov
genom
highli
variabl
abil
produc
amplicon
expect
size
patient
sampl
although
posit
control
materi
consist
yield
expect
product
tabl
failur
may
due
ineffici
hybrid
amplif
primer
andor
probe
target
sequenc
insuffici
target
nucleic
acid
patient
sampl
sampl
obtain
viru
excret
high
concentr
patient
infect
sarscov
ineffici
extract
nucleic
acid
sampl
inhibitori
substanc
pcr
mixtur
viral
load
detect
limit
assay
note
experi
sarscov
specif
primer
vari
describ
laboratori
exampl
worker
describ
success
rate
amplifi
sarscov
target
sequenc
patient
sampl
use
primer
given
viral
load
patient
may
vari
sampl
locat
sensit
detect
method
critic
factor
rapid
identif
infect
patient
order
implement
prompt
treatment
limit
spread
viru
use
primer
describ
tabl
convent
pcr
detect
specif
region
sarscov
rnadepend
rna
polymeras
gene
variabl
success
amplifi
product
expect
size
nucleic
acid
extract
obtain
patient
diagnos
suspect
probabl
sar
case
tabl
neg
pcr
result
due
presenc
pcr
inhibitor
sampl
rule
spike
weakli
posit
control
pcr
spike
sampl
gave
pcr
product
expect
size
data
shown
posit
control
materi
amplifi
ident
condit
consist
produc
band
expect
size
agaros
gel
follow
electrophoresi
data
shown
likewis
taqman
realtim
pcr
protocol
produc
similar
variabl
result
sampl
analyz
tabl
inhibit
cellular
compon
sampl
exclud
caus
failur
detect
sarscov
low
number
posit
pcrrealtim
signal
might
due
low
concentr
templat
sampl
enhanc
realtim
pcr
method
develop
increas
sensit
sarscov
detect
first
bp
region
sarscov
polymeras
gene
amplifi
cdna
convent
pcr
amplicon
sequenc
confirm
correspond
expect
region
sarscov
data
shown
pcr
product
subsequ
use
templat
enhanc
realtim
pcr
protocol
use
set
primer
protocol
patient
sampl
identifi
sarscov
posit
compar
standard
realtim
method
averag
variou
convent
pcr
method
tabl
suitabl
neg
posit
pcr
inhibit
control
use
stage
amplif
procedur
data
shown
select
standard
enhanc
realtim
pcr
data
clinic
sampl
shown
fig
clear
differenti
sarscov
posit
sarscov
neg
sampl
obviou
fig
indic
arrow
discrimin
posit
neg
signal
ambigu
sampl
analyz
standard
realtim
pcr
sarscov
posit
neg
amplif
curv
tend
overlap
close
one
anoth
fig
therefor
clinician
less
experienc
interpret
realtim
pcr
result
distinguish
easili
posit
neg
signal
enhanc
result
obtain
enhanc
realtim
pcr
method
result
lower
cycl
time
ct
valu
sarscov
posit
sampl
compar
convent
realtim
pcr
method
ct
valu
suitabl
cutoff
distinguish
unambigu
sampl
contain
sarscov
nucleic
acid
minor
limit
method
possibl
quantifi
amount
viru
sampl
exponenti
increas
copi
number
preamplif
stage
mask
initi
templat
concentr
realtim
amplif
step
viral
cultur
posit
sarscov
sampl
tabl
three
case
detect
cultur
also
detect
enhanc
realtim
pcr
method
least
one
pcr
method
use
primer
differ
region
sarscov
genom
viral
cultur
may
detect
sarscov
posit
sampl
due
low
infect
viru
presenc
high
concentr
damag
mispackag
otherwis
nonviabl
virion
contrast
nucleic
acid
base
detect
method
may
adequ
identifi
viru
particl
specif
primer
probe
examin
two
method
first
sequenc
comparison
use
ncbi
genbank
databas
nucleic
acid
comparison
tool
eg
blast
blast
sequenc
perform
signific
sequenc
similar
observ
primerprob
queri
sequenc
sequenc
especi
deriv
upper
respiratori
tract
pathogen
includ
human
coronavirus
second
primer
probe
use
directli
attempt
amplif
seri
known
pathogen
singlestrand
rna
genom
eg
influenza
b
respiratori
syncyti
viru
paramyxoviru
type
type
polioviru
organ
isol
viral
cultur
includ
adenoviru
parainfluenza
herp
simplex
viru
amplif
product
detect
tabl
addit
enhanc
realtim
pcr
method
success
detect
sarscov
genet
materi
isol
patient
two
distinct
outbreak
cluster
hong
kong
separ
geograph
tempor
limit
detect
amplif
method
determin
serial
dilut
total
nucleic
acid
extract
cultur
sampl
sarscov
tcid
ml
obtain
patient
hong
kong
limit
detect
convent
pcr
standard
realtim
pcr
enhanc
realtim
pcr
method
equival
tcid
ml
tcid
ml
fig
tcid
ml
fig
respect
thu
enhanc
realtim
pcr
method
least
fold
sensit
standard
realtim
pcr
fold
sensit
convent
pcr
techniqu
current
use
molecular
detect
sarscov
detect
sarscov
viral
cultur
may
least
sensit
method
shown
tabl
case
detect
enhanc
realtim
pcr
posit
sarscov
viral
cultur
due
rel
difficulti
cultur
sarscov
lack
serolog
data
mani
patient
includ
studi
possibl
estim
diagnost
sensit
specif
commonli
held
gold
standard
method
number
true
sarscov
posit
neg
patient
among
suspect
patient
unknown
lack
corrobor
clinic
data
explain
part
condit
surround
sampl
collect
earli
stage
sar
outbreak
hong
kong
littl
known
novel
viru
sampl
undertaken
simpli
identifi
caus
agent
outbreak
rapid
hospit
soon
overwhelm
patient
necessit
rapid
implement
control
measur
prevent
spread
sarscov
may
led
inconsist
way
sampl
collect
six
case
enhanc
realtim
pcr
method
detect
sarscov
posit
sampl
confirm
assay
tabl
six
case
four
report
hong
kong
depart
health
dh
probabl
sar
includ
list
case
submit
two
case
symptom
clinic
compat
pneumonia
viral
cultur
neg
case
neither
case
report
dh
probabl
sar
one
case
sar
exclud
definit
note
viru
cultur
patient
sarscov
nucleic
acid
demonstr
present
multipl
pcr
test
addit
serolog
data
sar
like
persist
global
diseas
must
consid
patient
upper
respiratori
tract
infect
present
vaccin
sarscov
specif
drug
intervent
may
becom
avail
short
term
ever
anim
model
diseas
current
avail
new
detect
method
improv
accuraci
diagnosi
valuabl
addit
panopli
diagnost
tool
avail
clinician
increas
sensit
enhanc
realtim
pcr
describ
make
applic
mani
area
beyond
simpl
clinic
diagnosi
given
fomit
sewag
link
sar
outbreak
hong
kong
suitabl
appli
nucleic
acid
detect
method
environment
sampl
obviou
examin
surfac
public
area
lift
wait
area
etc
evid
sarscov
nucleic
acid
provid
opportun
monitor
transmiss
diseas
also
monitor
effect
clean
steril
procedur
sign
symptom
sar
highli
variabl
especi
patient
highrisk
elderli
fever
exampl
often
present
sensit
method
determin
presenc
sarscov
would
use
limit
spread
viru
clinic
set
earli
detect
would
also
enabl
emerg
plan
implement
sooner
contain
local
outbreak
prevent
intern
spread
sarscov
limit
public
concern
potenti
econom
effect
preamplif
step
suggest
improv
sensit
detect
sarscov
clinic
sampl
analyt
sensit
specif
new
approach
demonstr
studi
requir
accur
determin
diagnost
sensit
specif
panel
sampl
known
infecti
statu
research
address
sensit
specif
enhanc
realtim
pcr
method
describ
ongo
appli
clinic
sampl
hospit
beij
forefront
sar
outbreak
china
new
assay
like
prove
import
earli
detect
sarscov
